Evidence map›Paper›PMID 40075690›Full record

ReviewCancers2025

Reduction of Prostate Cancer Risk: Role of Frequent Ejaculation-Associated Mechanisms.

Mohamed Hassan, Thomas W Flanagan, Abdulaziz M Eshaq, Osama K Altamimi, Hassan Altalag, Mohamed Alsharif, Nouf Alshammari, Tamadhir Alkhalidi, Abdelhadi Boulifa, Siraj M El Jamal and 2 more

Abstract readReview
In one paragraph

Review in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mohamed HassanInstitut National de la Santé et de la Recherche Médicale, University of Strasbourg, 67000 Strasbourg, France.ORCID 0000-0002-0336-6425
Thomas W FlanaganDepartment of Pharmacology and Experimental Therapeutics, LSU Health Sciences Center, New Orleans, LA 70112, USA.
Abdulaziz M EshaqResearch Laboratory of Surgery-Oncology, Department of Surgery, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Osama K AltamimiCollege of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.
Hassan AltalagCollege of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.ORCID 0009-0005-5232-8045
Mohamed AlsharifCollege of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.
Nouf AlshammariCollege of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.ORCID 0009-0002-9161-2119
Tamadhir AlkhalidiCollege of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.
Abdelhadi BoulifaBerlin Institute of Health, Charité University Hospital, 10117 Berlin, Germany.
Siraj M El JamalDepartment of Pathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA.
Youssef HaikelInstitut National de la Santé et de la Recherche Médicale, University of Strasbourg, 67000 Strasbourg, France.ORCID 0000-0002-4469-0360
Mossad MegahedClinic of Dermatology, University Hospital of Aachen, 52074 Aachen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate cancer (PCa) accounts for roughly 15% of diagnosed cancers among men, with disease incidence increasing worldwide. Age, family history and ethnicity, diet, physical activity, and chemoprevention all play a role in reducing PCa risk. The prostate is an exocrine gland that is characterized by its multi-functionality, being involved in reproductive aspects such as male ejaculation and orgasmic ecstasy, as well as playing key roles in the regulation of local and systemic concentrations of 5α-dihydrotestosterone. The increase in androgen receptors at the ventral prostate is the first elevated response induced by copulation. The regulation of prostate growth and function is mediated by an androgen-dependent mechanism. Binding 5-DHT to androgen receptors (AR) results in the formation of a 5α-DHT:AR complex. The interaction of the 5α-DHT:AR complex with the specific DNA enhancer element of androgen-regulated genes leads to the regulation of androgen-specific target genes to maintain prostate homeostasis. Consequently, ejaculation may play a significant role in the reduction of PCa risk. Thus, frequent ejaculation in the absence of risky sexual behavior is a possible approach for the prevention of PCa. In this review, we provide an insight into possible mechanisms regulating the impact of frequent ejaculation on reducing PCa risk.

Indexed as

5?-dihydrotestosterone5?-reductase-2prostate cancertestosterone

Identifiers

PMID40075690
PMCPMC11898507

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.